Marco Pappagallo

Marco Pappagallo

Corporate Officer/Principal at Sapienza University of Rome

66 year
Consumer Services
Health Technology
Health Services

Profile

Marco Pappagallo is the founder of Novapharm Therapeutics, which was founded in 2010.
He held the title of Chief Medical Officer at Novapharm Therapeutics.
Currently, Dr. Pappagallo is a Professor at Sapienza University of Rome.
In the past, he worked as the Director-Chronic Pain at Beth Israel Medical Center, The Johns Hopkins University, and Icahn School of Medicine at Mount Sinai.
He also served as the Director-Pain Research & Professor-Anesthesiology at The Mount Sinai Medical Center, Inc. Additionally, Dr. Pappagallo worked as the Executive Director-Medical Intelligence at Grünenthal USA, Inc. and as a Professor at Albert Einstein College of Medicine, Inc. He was also the Chief Medical Officer at Cersci Therapeutics, Inc. Currently, Dr. Pappagallo is the Chief Clinical Officer at Relmada Therapeutics, Inc. from 2020 to 2023.
Dr. Pappagallo obtained a doctorate degree from The American University of Rome.

Marco Pappagallo active positions

CompaniesPositionStart
Sapienza University of Rome Corporate Officer/Principal -
All active positions of Marco Pappagallo

Former positions of Marco Pappagallo

CompaniesPositionEnd
RELMADA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/01/2023
Albert Einstein College of Medicine, Inc. Corporate Officer/Principal 01/01/2014
Corporate Officer/Principal -
The Johns Hopkins University Corporate Officer/Principal -
Icahn School of Medicine at Mount Sinai Corporate Officer/Principal -
See the detail of Marco Pappagallo's experience

Training of Marco Pappagallo

The American University of Rome Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marco Pappagallo's experience

Connections

25

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
RELMADA THERAPEUTICS, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Novapharm Therapeutics

Health Services

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Marco Pappagallo